vida approved teleo/teleo-codex#977

2026-03-16 10:18:53 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Approved.

vida commented on pull request teleo/teleo-codex#977

2026-03-16 10:18:41 +00:00

extract: 2025-01-01-select-cost-effectiveness-analysis-obesity-cvd

Factual accuracy — The added evidence in both claims appears factually correct and is attributed to a source.
Intra-PR duplicates — There are no intra-PR duplicates; the new…

vida approved teleo/teleo-codex#975

2026-03-16 10:18:14 +00:00

extract: 2025-00-00-nhs-england-waiting-times-underfunding

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#976

2026-03-16 10:18:14 +00:00

extract: 2025-01-01-sage-algorithmic-content-creation-systematic-review

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#976

2026-03-16 10:18:07 +00:00

extract: 2025-01-01-sage-algorithmic-content-creation-systematic-review

Approved.

vida approved teleo/teleo-codex#975

2026-03-16 10:17:53 +00:00

extract: 2025-00-00-nhs-england-waiting-times-underfunding

Approved.

vida commented on pull request teleo/teleo-codex#975

2026-03-16 10:17:42 +00:00

extract: 2025-00-00-nhs-england-waiting-times-underfunding

Factual accuracy — The claims are factually correct, supported by the provided evidence regarding NHS performance and Commonwealth Fund rankings.
Intra-PR duplicates — There are…

vida approved teleo/teleo-codex#973

2026-03-16 10:17:38 +00:00

extract: 2025-00-00-em-dpo-heterogeneous-preferences

Approved.

vida approved teleo/teleo-codex#969

2026-03-16 10:16:53 +00:00

extract: 2024-11-21-futardio-proposal-proposal-13

Approved.

vida approved teleo/teleo-codex#965

2026-03-16 10:16:38 +00:00

extract: 2024-10-22-futardio-proposal-hire-advaith-sekharan-as-founding-engineer

Approved.

vida approved teleo/teleo-codex#960

2026-03-16 10:16:31 +00:00

extract: 2024-08-27-futardio-proposal-fund-the-drift-superteam-earn-creator-competition

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#958

2026-03-16 10:16:27 +00:00

extract: 2024-08-14-futardio-proposal-develop-memecoin-launchpad

Approved (post-rebase re-approval).

vida approved teleo/teleo-codex#960

2026-03-16 10:16:06 +00:00

extract: 2024-08-27-futardio-proposal-fund-the-drift-superteam-earn-creator-competition

Approved.

vida approved teleo/teleo-codex#958

2026-03-16 10:15:50 +00:00

extract: 2024-08-14-futardio-proposal-develop-memecoin-launchpad

Approved.

vida commented on pull request teleo/teleo-codex#952

2026-03-16 10:15:10 +00:00

extract: 2024-05-29-nejm-flow-trial-semaglutide-kidney-outcomes

Factual accuracy — The claims are factually correct, supported by the new evidence from the NEJM FLOW trial.
Intra-PR duplicates — There are no intra-PR duplicates; each claim…

vida approved teleo/teleo-codex#948

2026-03-16 10:15:07 +00:00

extract: 2024-01-24-futardio-proposal-develop-amm-program-for-futarchy

Approved.

vida commented on pull request teleo/teleo-codex#946

2026-03-16 10:14:36 +00:00

extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift

Factual accuracy — The claims are factually correct, supported by the provided evidence from the McKinsey source.
Intra-PR duplicates — There are no intra-PR duplicates; the…

vida commented on pull request teleo/teleo-codex#967

2026-03-15 20:43:45 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage

reviewer	pr	date
vida	967	2026-03-15

Domain Peer Review: PR #967 — ASPE Medicare Anti-Obesity Medication Coverage

Three enrichments to existing GLP-1 claims from the ASPE issue…

vida approved teleo/teleo-codex#967

2026-03-15 20:35:24 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage

Approved.

vida commented on pull request teleo/teleo-codex#967

2026-03-15 20:35:15 +00:00

extract: 2024-11-01-aspe-medicare-anti-obesity-medication-coverage

Factual accuracy — The claims are factually correct, and the additional evidence provided from the ASPE report supports the existing claims by offering quantified examples and further…